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Abbreviations List 
100SS  100 minute steady state ride 
ACC  Acetyl CoA carboxylase 
ADP  Adenosine diphosphate 
AMPK  AMP-activated protein kinase 
AU  Arbitrary unit 
βHB  βeta-hydroxybutyrate concentration 
BIOPS  Biopsy preservation solution 
BM  Body mass 
CHO  Carbohydrate 
CI  Mitochondrial complex I 
CII  Mitochondrial complex II 
CIII  Mitochondrial complex III 
CIV  Mitochondrial complex IV 
CV  Mitochondrial complex V 
CPT1a  Carnitine palmitoyltransferase-1 
CS  Citrate synthase 
DM  Dry mass 
DTT  Dithiothreitol 
EGTA  Ethylene glycol-bis (β-aminoethyl ether)-N,N,N’,N’-tetraacetic acid 
EI  Energy intake 
ETF  Electron-transferring flavoprotein (leak state respiration) 
ETFp  Electron-transferring flavoprotein (ADP stimulated oxidative phosphorylation) 
ETS  Electron transport system (respiratory capacity during uncoupled state) 
FA  Fatty acid 
FAT/CD36 Fatty acid translocase / CD36 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase 
HDL  High density lipoprotein 
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HR  Heart rate 
LDL  Low density lipoprotein 
mTOR  Mammalian target of rapamycin  
OXPHOS Oxidative phosphorylation 
PDH  Pyruvate dehydrogenase 
PPO  Peak power output 
PO   Power output 
RER  Respiratory exchange ratio 
RPE  Rate of perceived exertion 
RPS6   S6 ribosomal protein 
SUIT  Substrate-uncoupler-inhibitor titration 
TT  Time-trial 
V̇O2peak  Peak oxygen uptake 
V̇CO2  Volume of carbon dioxide produced 
V̇O2  Volume of oxygen consumed 
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Abstract  
 
High-fat, low-carbohydrate (CHO) diets increase whole-body rates of fat oxidation and down-
regulate CHO metabolism. We measured substrate utilization and skeletal muscle mitochondrial 
respiration to determine if these adaptations are driven by high-fat or low-CHO availability. In a 
randomized crossover design, eight male cyclists consumed five days of a high-CHO diet (HCHO, 
> 70% energy intake (EI)), followed by five days of either an isoenergetic high-fat (HFAT, > 65% 
EI) or high-protein diet (HPRO, > 65% EI) with CHO intake ‘clamped’ at < 20% EI. During the 
intervention, participants undertook daily exercise training. On day six, participants consumed a 
high-CHO diet, prior to undertaking 100 min of submaximal steady state cycling plus a ~30 min 
time trial. Following five days of HFAT, skeletal muscle mitochondrial respiration supported by 
octanoylcarnitine and pyruvate as well as uncoupled respiration was decreased at rest, and rates of 
whole-body fat oxidation were higher during exercise compared to HPRO. Following one day of 
HCHO intake, mitochondrial respiration returned to baseline values in HFAT while rates of 
substrate oxidation returned towards baseline in both conditions. These findings demonstrate that 
high dietary fat rather than low-CHO intake contributes to reductions in mitochondrial respiration 
and increases in whole-body rates of fat oxidation following a high-fat, low-CHO diet. 
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Introduction  
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High-fat, low-carbohydrate (CHO) diets have increased in popularity over the past two decades 
with regards to their efficacy for improving both metabolic health profiles [1] and athletic 
performance [2, 3]. Short-term (1-3 week) ingestion of a high-fat, low-CHO diet when compared 
with an isoenergetic high-CHO diet for the same duration increases rates of whole-body and 
muscle fat utilization and decreases the rate of muscle glycogenolysis during submaximal exercise 
[2, 4-6]. Such metabolic perturbations are robust and persist in the face of high-CHO availability 
from both endogenous and exogenous sources [4, 7, 8]. Impaired glycogenolysis as a consequence 
of high-fat, low-CHO diets has been explained by decreased pyruvate dehydrogenase (PDH) 
activation [5], suggesting impaired metabolic flexibility in skeletal muscle. A range of alterations 
in the activities of regulatory enzymes and/or signaling proteins in the pathways underlying 
skeletal muscle fat and CHO metabolism are likely to explain the changes observed with 
adaptation to a high-fat diet. However, to date it has not been possible to determine whether such 
adaptations are driven by high-fat or low-CHO availability as the protocols used in previous 
studies involved changes to both macronutrients simultaneously [2, 4, 5, 7]. Therefore, in order to 
elucidate the underlying mechanisms driving changes in metabolic flexibility, high-fat dietary 
intake must be compared to an isoenergetic diet, where CHO intake is clamped in both dietary 
interventions. Few studies have determined changes to skeletal muscle in well-trained humans 
following a high-fat diet and to date, no study has assessed mitochondrial respiration in this 
population to determine if this could explain changes in metabolic flexibility.  
 
Therefore, the current investigation aimed to determine whether the metabolic perturbations 
induced by a high-fat diet are a result of high-fat or low-CHO availability. Well-trained humans 
were fed five days of either a high-fat diet or an isoenergetic high-protein diet (~65% energy intake 
(EI)) with CHO intake ‘clamped’ to < 20% of total daily EI (2.6 g·kg-1 body mass). We utilized 
whole-body expired gas measures together with assessment of skeletal muscle substrates, 
mitochondrial respiration and signaling proteins with putative roles in substrate metabolism in an 
effort to identify mechanisms underlying changes in the patterns of substrate oxidation observed 
following a high-fat diet. We hypothesized that whole body rates of fat oxidation would be greater 
following high-fat compared to a high-protein diet due to high-fat rather than low-CHO availability 
driving the shifts in fuel utilization and skeletal muscle mitochondrial respiration.  
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Materials and Methods 
Ethical Approval 
This study conformed to the standards set by the Declaration of Helsinki and was approved by the 
Human Research Ethics Committee of Australian Catholic University and registered with the 
Australian New Zealand Clinical Trials Registry (ACTRN12616000433404). Participants 
completed a medical history questionnaire to ensure they were free from illness and injury before 
commencing the study and were informed of all experimental procedures and possible risks prior 
to providing their written, informed consent.  
Overview of study design 
Eight well-trained male cyclists with a history of endurance training and riding > 200 kmˑweek-1 
were recruited for this study. Participant characteristics were: age, 25 ± 4 (SD) y; body mass (BM), 
77.3 ± 7.0 kg; V̇O2peak, 64.0 ± 3.5 mLˑkgˑmin-1; peak power output (PPO), 380 ± 36 W. An 
overview of the study design is shown in Figure 1. Each participant completed two experimental 
conditions in a block randomized, crossover design while undertaking supervised training. There 
was a ~14 day wash out period between conditions. It was not possible to blind participants to the 
dietary interventions. However, the principal researchers completing the data collection and 
performance measures were blinded to the order of experimental trials. 
Preliminary testing  
Each participant completed an incremental test to volitional fatigue on an electronically braked 
cycle ergometer (Lode Excalibur Sport, Groningen, Netherlands) to determine V̇O2peak and PPO 
[9].  During the maximal test and all subsequent experimental trials, expired gas was collected 
every 30 s via open-circuit spirometry (TrueOne 2400; Parvo Medics, Sandy, UT) and the 
instantaneous rates of O2 consumption (V̇O2) and CO2 production (V̇CO2) were used to calculate 
the respiratory exchange ratio (RER). Before each test, gas analyzers were calibrated with 
commercially available gases (16% O2, 4% CO2) and volume flow was calibrated using a 3 L 
syringe. An individual’s V̇O2peak was determined as the highest 30-s average. These data were 
used to calculate the work rate corresponding to 63% and 80% of PPO for the two experimental 
rides.  
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Experimental trials 
Participants followed a ‘controlled’ high-CHO diet (72% EI), 10 gˑkg-1 BM [HCHO]) for five days 
prior to an experimental trial (see Table 1). Participants reported to the lab on the 5th day after an 
overnight fast and a resting blood sample (6 mL) was collected from an antecubital vein. 
Participants were then provided a standardized breakfast (2 gˑkg-1 BM CHO). Two hours following 
breakfast, participants were weighed and a second blood sample was collected before they 
completed a 20 min continuous ride at 63% PPO. Expired gas and measures of heart rate (HR) and 
rating of perceived exertion (RPE) were collected during the last 5 min of the ride [10].  Water 
was consumed ad libitum and upon completion of the ride, a third blood sample was collected 
prior to participants leaving the lab for the final (5th) day of the HCHO diet.   
The following morning, participants reported to the lab overnight fasted and a cannula (22G; 
Terumo, Tokyo, Japan) was inserted into an antecubital vein and a resting blood sample (6 mL) 
was collected. A resting muscle biopsy was then taken from the vastus lateralis using the 
percutaneous biopsy technique with suction applied [11]. Participants then repeated the 20 min 
continuous ride at 63% PPO in the fasted state, before commencing a high-intensity interval 
session (HIIT) (8 x 5 min at 80% PPO), as previously described [12]. The purpose of this interval 
session was to reduce muscle glycogen stores in both conditions prior to the dietary intervention.  
Diet and Training Intervention 
Participants commenced five days of either a high-fat (HFAT) or a high-protein (HPRO) diet. The 
HFAT and HPRO diets comprised 67% EI from fat or protein and 19% EI from CHO (Table 1). 
Protein was provided as an alternative macronutrient to meet energy requirements, while CHO 
was ‘clamped’. Total EI was 0.22 MJˑkg-1 BM. The HFAT diet was comprised of ~55% saturated 
and 45% unsaturated (mono and polyunsaturated) fats. Fiber intake was matched for both diets. 
All meals, snacks and energy-containing fluids were provided to participants in pre-prepared 
packages, with diets individualized for food preference. Participants completed a daily food 
checklist to maximize compliance and recorded all fluid (water) consumed on a daily basis during 
both trials. Caffeine ingestion was not permitted 24 h prior to an experimental trial and participants 
refrained from alcohol during the intervention period. During this time, participants followed a 
prescribed training program described previously [2] that closely matched each individual’s 
habitual road cycle training volume. Training was matched for each experimental treatment and 
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participants were instructed to ride at a rating of perceived exertion (RPE) that corresponded to 
11-13 [10] during each on-road session. Participants reported to the lab on day 4 and completed 
the same HIIT session as on day 1. On the morning of day 6, participants reported to the lab in a 
fasted state and a resting blood sample (6 mL) and muscle biopsy were collected before they 
completed a 20 min ride at 63% PPO. Participants were then provided with 1 day of a high-CHO 
diet (10 gˑkg-1 BM CHO) (Table 1). 
 
Performance ride 
After an overnight fast participants reported to the laboratory to complete a performance ride 
consisting of 100 min steady state (100SS) cycling at 63% PPO, followed by a 7 kJˑkg-1 BM time 
trial (TT). On arrival at the laboratory, a cannula was inserted into an antecubital vein and a fasted 
blood sample (10 mL) was collected. A muscle biopsy was then taken 2-3 cm distal from the 
previous incision. Participants then consumed breakfast (2 gˑkg-1 BM CHO) and rested for 120 
min. Immediately prior to exercise participants were weighed and a second blood sample was 
collected. During exercise blood samples (10 mL) and measures of RPE and HR were collected 
every 20 min, with expired gas collected at 15, 35, 55, 75, and 95 min. Participants were provided 
with CHO in the form of isotonic gels (SiS GO Isotonic Gel; Blackburn, UK) and a 6% CHO 
solution (933 mL fluid, 2 gels total) every 20 min throughout the ride at a rate of 60 gˑh-1 and water 
was consumed ad libitum during each trial. Immediately upon completion of the 100SS ride, a 
further muscle biopsy was taken. Participants then voided their bladder and had a 3 min rest prior 
to commencing the TT. Participants were instructed to complete the TT as fast as possible with 
visual feedback of cadence and verbal feedback of elapsed work as a percentage of the total work 
(every 10%). Participants were only provided the results of their TT performance upon study 
completion. Blood samples were collected immediately before and after the TT. 
 
Rates of substrate oxidation and total energy expenditure 
Whole body rates of CHO and fat oxidation (gˑmin-1) were calculated from respiratory gas samples 
collected during rides using the non-protein RER equations [13] which are based on the 
assumption that VȮ2 and VCȮ2 accurately reflect tissue O2 consumption and CO2 production:  
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CHO oxidation (gˑmin-1) = 4.585 V̇CO2 (Lˑmin-1) - 3.226 V̇O2 (Lˑmin-1) 
Fat oxidation (gˑmin-1) = 1.695 V̇O2 (Lˑmin-1) - 1.701 V̇CO2 (Lˑmin-1).  
 
Rates of CHO and fatty acid oxidation (μmol·kg·min-1) were calculated by converting the rates of 
oxidation (gˑkg·min-1) to their molar equivalent. It was assumed that 6 moles of O2 is consumed 
and 6 moles of CO2 is produced for each mole of CHO (180 g) oxidized and that the molecular 
mass of human triacylglycerol is 855.3 g·mol-l. The molar rates of triacylglycerol oxidation were 
multiplied by 3 because each molecule contains 3 moles fatty acid.  
 
Blood sampling and analyses 
Blood samples (6-10 mL) were collected into vacutainers containing EDTA and immediately 
analyzed for blood lactate (YSI 2900 STAT Plus, Yellow Springs, OH, USA) and total cholesterol, 
high density lipoproteins (HDL), low density lipoproteins (LDL) and triglycerides (Cobas b 101, 
Roche Diagnostics Ltd, Basel, Switzerland). The remaining sample was then centrifuged at 1,500 
g for 10 min at 4 °C, and aliquots of plasma were stored at -80 °C for later analysis of FFA (Wako 
Pure Chemical Industries, Ltd, Osaka, Japan), glycerol (Sigma-Aldrich, Ltd, Australia), insulin 
(R-Biopharm – Laboratory Diagnostics Pty Ltd, NSW, Australia), βeta-hydroxybutyrate (βHB) 
(Sigma-Aldrich, Ltd, Australia) and glucose (Melbourne Pathology, Vic, Australia) concentration. 
 
Mitochondrial respiration analyses 
Vastus lateralis muscle biopsies were excised and 10-20 mg was immediately placed into 3 mL of 
ice-cold biopsy preservation solution (BIOPS) [2.77 mM CaK2 ethylene glycol-bis(β-aminoethyl 
ether)-N,N,N’,N’-tetraacetic acid (EGTA), 7.23 mM K2EGTA, 5.77 mM Na2ATP, 6.56 mM 
MgCl2·6 H2O, 20 mM taurine, 15 mM Na2Phosphocreatine, 20 mM imidazole, 0.5 mM 
dithiothreitol (DTT), 50 mM MES hydrate; pH 7.1]. Muscle fibers were mechanically separated 
in ice-cold BIOPS to maximize fiber surface area and transferred into ice-cold BIOPS 
supplemented with saponin (50 μg·mL-1) for 30 min with agitation to permeabilize the sarcolemma 
and allow diffusion of substrates. Fibers were then washed 3 times via agitation in ice-cold MiR05 
respiration medium (20 mM 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid (HEPES), 0.5 
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mM EGTA, 10 mM KH2PO4, 3 mM MgCl2·6H2O, 60 mM lactobionic acid, 20 mM taurine, 110 
mM D-sucrose, 1 g·L-1 bovine serum albumin (BSA); pH 7.1). Fiber bundles were divided and 
weighed on a microbalance (1.5-3 mg each) for respirometry analysis in duplicate. All respiration 
analyses were commenced within 1 h of sampling.  
Electron transport system (ETS) and oxidative phosphorylation (OXPHOS) respiration were 
measured by the Oxygraph O2k high resolution respirometer (Oroboros Instruments, Innsbruck, 
Austria) via a substrate-uncoupler-inhibitor titration (SUIT) protocol at 37 °C in MIR05 respiration 
medium with magnetic stirring at 750 rpm. Briefly, after fibers were added and O2 was injected to 
the respiration chamber (maintained between 300 and 500 pmol), the sequential addition SUIT 
protocol commenced with titrations of malate (2 mM final concentration) and octanoylcarnitine 
(0.2 mM) to determine leak electron-transferring flavoprotein (ETF) respiration. OXPHOS ETF 
(ETFp) respiration was assessed by addition of adenosine diphosphate (ADP; 5 mM), complex I 
(CI) substrate pyruvate (5 mM) and complex II (CII) substrate succinate (10 mM). Cytochrome c 
(10 μM) was added to confirm mitochondrial membrane integrity, and titrations of carbonyl 
cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP; 0.025 μM) were added to determine 
uncoupled respiratory flux. Complex-specific respiration was inhibited by the addition of rotenone 
(1 μM) and antimycin A (5 μM) to CI and complex III (CIII), respectively. Finally, complex IV 
(CIV) capacity was measured during oxidation of N,N,N',N'-Tetramethyl-p-phenylenediamine 
dihydrochloride (TMPD; 0.5 mM) with ascorbate (2 mM). O2 flux due to auto-oxidation of these 
chemicals was determined after inhibition of complex IV (CIV) with sodium azide (15 mM) then 
subtracted from the raw CIV O2 flux. Chamber O2 concentration was maintained between 300 and 
450 μmolˑL-1. Mass-specific O2 flux was determined from steady-state flux normalized to tissue 
wet weight and adjusted for instrumental background and residual O2 consumption. 
 
Muscle glycogen concentration 
Muscle glycogen concentration was determined as described previously [14]. In brief, ~20 mg of 
muscle was freeze-dried and powdered, with all visible connective tissue removed under a 
microscope. Glycogen was then extracted from the freeze-dried sample and glycogen 
concentration was determined via enzymatic analysis [15].  
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Citrate synthase activity 
Whole skeletal muscle lysates were prepared at a concentration of 2 mgˑmL-1 and 5 μL of sample 
was loaded onto a 96-well microtiter plate with 40 μL of 3 mM acetyl CoA, and 25 μL of 1 mM 
5,5’-dithiobis [2-nitrobenzoic acid] (DTNB) in 165 μL of 100 mM Tris buffer (pH 8.3). 
Subsequently, 15 μL of 10 mM oxaloacetic acid was added to each well and immediately analyzed 
using a SpectraMax Paradigm plate reader (Molecular Devices, Sunnyvale, CA). Absorbance was 
read at 412 nm and was recorded every 15 s for 3 min after 30 s of linear agitation. Maximal 
activity was recorded with citrate synthase activity reported in molˑhˑkg-1 protein. 
Protein analyses 
For generation of whole skeletal muscle lysates, ~40 mg of skeletal muscle was homogenized in 
buffer containing 50 mM Tris·HCl, pH 7.5, 1 mM EDTA, 1 mM EGTA, 10% glycerol, 1% Triton 
X-100, 50 mM sodium fluoride, 5 mM sodium pyrophosphate, 1 mM DTT, 10 μg/mL trypsin 
inhibitor, 2 μgˑmL-1 aprotinin, 1 mM benzamidine, and 1 mM phenylmethylsulfonyl fluoride. 
Samples were spun at 16,000 g for 30 min at 4°C and supernatant was collected. After 
determination of protein concentration via bicinchoninic acid protein assay (Pierce, Rockford, IL), 
lysates were resuspended in Laemmli sample buffer and 10 µg protein of each sample was loaded 
into 4–20% Mini-PROTEAN TGX Stain-Free Gels (Bio-Rad Laboratories, California, USA). For 
OXPHOS antibody cocktail, 8.5 µg protein from unboiled lysates were loaded into 12% 
polyacrylamide gels. Following electrophoresis, gels were activated according to the 
manufacturer's instructions (Chemidoc; Bio-Rad Laboratories, Gladesville, Australia) and 
transferred to polyvinylidine fluoride (PVDF) membranes. After transfer, a Stain-Free image was 
obtained for protein loading normalization before rinsing membranes briefly in distilled water, 
blocking for 1 h with 5% nonfat milk, washing three times (5 min each wash) with 10 mM 
Tris·HCl, 100 mM NaCl, and 0.02% Tween 20 solution (TBST) and incubating with primary 
antibody diluted in TBST (1:1,000) overnight at 4°C on a shaker. Membranes were incubated for 
1 h the next day with a secondary antibody diluted in TBST (1:2,000) and proteins were detected 
via enhanced chemiluminescence (Amersham Biosciences, Buckinghamshire, UK; Pierce 
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Biotechnology) and quantified by densitometry (Chemidoc; Bio-Rad Laboratories). Time points 
and both diets for each subject were run on the same gel.  
Antibodies against fatty acid translocase (FAT/CD36) (no. 14347), Carnitine palmitoyltransferase-
1 (CPT1A) (no. 12252), AMP-activated protein kinase (AMPKα) (no. 2532), phospho-
AMPKThr172 (no. 2531), Acetyl CoA Carboxylase  (ACC) (no.3662), phospho-ACCSer79 (no.3661), 
mammalian target of rapamycin (mTOR) (no. 2972), phospho-mTORSer2448 (no. 2971), S6 
Ribosomal Protein RPS6 (no. 2217), phospho-RPS6Ser235/236 (no. 2211), Citrate Synthase (no. 
14309), Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (no. 2118) were purchased from 
Cell Signaling Technology (Danvers, MA) and total OXPHOS (no. 110411) purchased from 
Abcam (Cambridge, UK). Volume density of each target band was normalized to total protein 
loaded into each lane using Stain-Free technology (Bio-Rad Laboratories), excluding OXPHOS 
cocktail which was normalized to GAPDH imaged from the same membrane following the 
addition of stripping buffer (Thermo Fisher Scientific) to the OXPHOS membrane and re-probing 
for GAPDH. Following protein loading normalization, each phosphoprotein was then normalized 
to its respective total protein. 
Statistics 
Statistical analysis was undertaken using SPSS (Version 20 for Windows, SPSS Inc, Chicago, IL). 
Data from the two experimental conditions were analyzed using a linear mixed model (treatment 
× time) and subsequent post hoc comparisons were completed within the linear mixed model based 
on least significant difference. Separate analysis was completed to compare day five of high-CHO 
diet to 100SS (fed) and day one of HFAT or HPRO to five days post-diet (fasted). Normality was 
visually assessed using the linear model residuals. Differences in TT performance between trials 
were compared using a Student’s paired t-test.  Statistical significance was considered at P < 0.05. 
All data are represented as mean ± SD. 
 
Results  
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All participants complied with the prescribed dietary (Table 1) and training intervention for both 
conditions. No difference was reported across the 5-day intervention periods for distance covered 
or RPE during training for either diet (HFAT, 222 ± 23 km, 13 ± 0.5; HPRO, 196 ± 29 km, 13 ± 
0.7 respectively).   
 
Muscle glycogen concentrations  
There was a significant main effect of time for muscle glycogen concentration (P < 0.001) (Figure 
2). Muscle glycogen was reduced in both HFAT and HPRO conditions pre- to post-diet (P < 
0.001). Following one day of high-CHO diet, muscle glycogen increased by ~45% in both HFAT 
and HPRO conditions (P < 0.001) but was not restored back to pre-diet values in HFAT (P < 
0.001). Following 100SS, muscle glycogen was reduced in both HFAT and HPRO conditions (526 
± 86 to 411 ± 62 mmol·kg-1 dry mass (DM), P=0.033; 637 ± 87 to 420 ± 92 mmol·kg-1 DM, P < 
0.001, respectively); however, no difference in the percentage change from pre- to post-exercise 
was measured between conditions. 
 
Rates of substrate oxidation 
There was a significant interaction effect for RER and rates of CHO and fat oxidation (all P = 
0.001) (Figure 3A, B, C) after five days of either HFAT or HPRO diet. RER was reduced pre- to 
post-diet for both HFAT and HPRO (0.90 ± 0.02 to 0.79 ± 0.02; 0.90 ± 0.03 to 0.86 ± 0.02, P ≤ 
0.001 respectively) and was lower post-diet in HFAT compared to HPRO (P < 0.001).  Rates of 
fat oxidation increased after five days of HFAT and HPRO and were greater in HFAT compared 
to HPRO post-diet (55 ± 7 vs. 36 ± 6 μmol·kg·min-1, P < 0.001). Concomitantly, rates of CHO 
oxidation were reduced pre- to post-diet in both conditions and were lower in HFAT than HPRO 
post-diet (106 ± 20 μmol·kg·min-1 vs. 169 ± 17 μmol·kg·min-1, P < 0.001). Following one day of 
high-CHO diet, RER values returned to baseline in the HPRO trial during the first 20 min of 
100SS, but remained lower than baseline in the HFAT trial (HFAT 0.93 ± 0.02 to 0.90 ± 0.03, P 
= 0.002). RER was lower in HFAT compared to HPRO during the first 40 min of 100SS (P < 
0.04). Following one day of high-CHO diet, rates of CHO oxidation were lower than baseline 
during 100SS following HFAT (P < 0.001) and were significantly lower during 100SS in HFAT 
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compared to HPRO (213 ± 35 vs. 241 ± 31 μmol·kg·min-1, P = 0.025, respectively). Rates of CHO 
oxidation declined throughout 100SS in HPRO (from 241 ± 31 to 215 ± 26 μmol·kg·min-1, P < 
0.001), but remained stable in HFAT (~208 μmol·kg·min-1). Despite one day of high-CHO diet, 
rates of fat oxidation remained elevated above baseline in the HFAT trial during the first 20 min 
of 100SS (P = 0.002) but returned to baseline in HPRO. During the first 20 min of 100SS, rates of 
fat oxidation were significantly higher in HFAT than HPRO (0.53 ± 0.11 vs. 0.38 ± 0.18 
μmol·kg·min-1, P = 0.010) and remained higher than HPRO after 40 and 80 min of exercise. Rates 
of fat oxidation increased during 100SS in both HFAT and HPRO (P < 0.05).   
 
Blood metabolites pre- and post-diet  
There was a main effect of time for FFA concentration (P < 0.001) pre- to post-diet. FFA 
concentration was greater following exercise post-diet compared to pre-diet in both HFAT (0.31 
mM to 0.58 mM, P < 0.001) and HPRO (0.33 to 0.56 mM, P < 0.001). There was a significant 
main effect of time (P = 0.013) and condition (P = 0.048) for LDL cholesterol. LDL cholesterol 
increased pre- to post-diet in HFAT (2.44 ± 0.63 to 2.93 ± 0.75 mM) and was higher than HPRO 
post-diet (2.93 ± 0.75 vs 2.55 ± 0.71, P = 0.025). There was a significant interaction for HDL 
cholesterol and triglycerides (P = 0.010, 0.042, respectively) between HFAT and HPRO. HDL 
cholesterol increased (1.01 ± 0.20 to 1.30 ± 0.23 mM, P < 0.001) pre-to post-diet to be greater than 
HPRO (1.08 ± 0.20 mM), while triglycerides decreased (1.26 ± 0.46 to 0.69 ± 0.36 mM, P = 0.001) 
to be lower than HPRO (1.06 ± 0.45 mM). No difference in total cholesterol was measured between 
conditions from pre- to post-diet. 
 
Blood metabolites during the performance ride   
There was a significant interaction for plasma glycerol concentration between HFAT and HPRO 
(P = 0.035; Figure 4A). Glycerol concentration increased significantly from rest after 60 min of 
exercise in HFAT and remained elevated until after the TT. Glycerol concentrations were 
significantly higher in HFAT than HPRO after 40 min of 100SS. There was a significant effect of 
time for plasma FFA (P < 0.001), although no differences were observed between diets (Figure 
4B). FFA concentrations decreased 2 h following CHO breakfast in both conditions and were 
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elevated from resting values after 60 min of 100SS until completion of the TT. Plasma βHB 
concentrations increased following CHO breakfast and remained stable during 100SS in both 
conditions until after the TT (Figure 4C). There was a main effect of time for blood lactate, blood 
glucose and plasma insulin concentrations (P < 0.001) during 100SS, but no differences between 
diets (Figure 4D-F). Blood glucose concentration decreased following CHO breakfast in both diets 
but following 40 min of exercise, glucose concentrations had increased back to resting values. 
Plasma insulin concentrations increased in both conditions after breakfast and remained elevated 
2 h after ingestion. After onset of exercise, insulin concentrations were reduced in both conditions 
and were similar to pre-breakfast values throughout 100SS. Following 100SS, participants 
ingested a CHO drink which increased insulin concentrations in both conditions, but this increase 
was abolished following the onset of the TT. Blood lactate concentrations remained stable 
throughout 100SS in both conditions and were higher post TT compared to rest in HFAT (3.1 ± 
1.1 mM) and HPRO (3.1 ± 1.0 mM). 
   
TT Performance    
There was no difference in TT performance between diet conditions (30:59 ± 2:55 vs. 30:10 ±2:70 
min:sec for HFAT and HPRO, respectively). Mean PO during the TT were 299 ± 34 W and 304 ± 
35 W (P = 0.41) and HR averaged 168 ± 9 bpm and 166 ± 7 b.min-1 in HFAT and HPRO, 
respectively. A significant reduction in BM was observed pre- to post-exercise (P < 0.04) for both 
HFAT (-0.86 ± 0.79 kg) and HPRO (-0.61 ± 0.83 kg), although there were no differences between 
conditions. No difference in RPE was reported between conditions during 100SS although RPE 
increased throughout the exercise in both HFAT and HPRO (from 11 ± 1 to 14 ± 1, P < 0.001).    
 
Skeletal muscle mitochondrial respiration 
Based on differences in whole-body substrate oxidation rates pre- to post-diet and during 
prolonged exercise between HFAT and HPRO (Figure 3), we next tested if skeletal muscle 
mitochondrial substrate utilization was contributing to this outcome using a sequential addition 
SUIT protocol. Absolute O2k respiration measures taken from permeabilized skeletal muscle fiber 
bundles analyzed in duplicate from each participant at each time point and under each diet are 
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reported in Table 2. To portray the effects of diet and exercise on mitochondrial respiration, 
percentage change data are represented in Figure 5. Although HFAT and HPRO absolute O2k 
values were not significantly different following either diet (Table 2), there was a significant 
interaction in percentage change of CI + ETFp respiration following HFAT and HPRO (P = 0.042; 
Figure 5A). The diet-induced reduction in CI + ETFp respiration following the addition of 
octanoylcarnitine and pyruvate was significantly greater following HFAT compared to HPRO. 
Despite no differences in absolute O2k values, percentage change of ETS uncoupled respiration 
(Figure 5A; ETS CI + CII + ETF; ETS CII) was significantly reduced following HFAT but not 
HPRO. Absolute and percentage change ETS CII uncoupled respiration remained unchanged 
following one day of high-CHO diet in HPRO but percentage change was significantly increased 
in HFAT compared to HPRO (P = 0.032, Figure 5B). ETFp respiration was significantly reduced 
following 100SS in HFAT but not HPRO (Figure 5C). Percentage change of post-exercise CI + 
ETFp, CI + CII + ETFp, ETS CI + CII + ETF, and ETS CII respiration was significantly reduced 
in both HFAT and HPRO (Figure 5C) despite no differences in absolute O2k values. The reduction 
in percentage change of CI + ETFp and CI + CII + ETFp respiration was greater in HFAT than 
HPRO following 100SS (P = 0.024, 0.019, respectively). There were no significant differences in 
skeletal muscle CS activity across time or between diets (~ 20 mol·h·kg-1) (Figure 5D).   
 
Immunoblot analyses 
Total protein contents of citrate synthase (Figure 5E) and OXPHOS complexes I-V (Figure 6A-F) 
were not different between HFAT and HPRO at any time point during intervention. OXPHOS 
complex III showed a trend towards a main effect for time (P = 0.073) with a decrease from pre- 
to post HFAT diet. There was a significant interaction for FAT/CD36 protein content (P < 0.001) 
from pre-diet to after one day of high-CHO diet (Figure 7A). FAT/CD36 protein content was 
higher pre- and post-diet and pre- and post-100SS in HFAT compared to HPRO. There were no 
differences in total CPT1a from pre- to post high-CHO diet in either HFAT or HPRO (Figure 7B). 
No main effects were found for AMPK Thr172 phosphorylation levels relative to total AMPK, 
although a trend towards a main effect of time was observed (P = 0.06) with an increase following 
HFAT (Figure 7C). There was an effect of time for ACC Ser79 phosphorylation relative to total 
ACC (P = 0.015). ACC Ser79 relative to total ACC was greater in HFAT following 100SS 
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compared to post HFAT (Figure 7D). There were no differences in mTOR Ser2448 
phosphorylation relative to total mTOR pre-diet compared to after one day of high-CHO (Figure 
7E). There was a significant effect of time for RPS6 Ser235/236 phosphorylation relative to total 
RPS6 (P < 0.05). RPS6 Ser235/236 phosphorylation increased following 100SS in HPRO 
compared to pre- and post-diet (Figure 7F).  RPS6 Ser235/236 phosphorylation was also higher 
post-exercise in HPRO compared to HFAT (P = 0.034). 
 
Discussion 
This is the first study to manipulate dietary fat and protein content while simultaneously 
‘clamping’ dietary CHO intake during a short-term period of intense exercise training in well-
trained humans. Such an experimental design is essential in an effort to pinpoint potential 
mechanisms underlying the high rates of fat oxidation reported following short-term adaptation to 
fat-rich diets, which persist even after one day of glycogen restoration with high-CHO intake [2, 
7] and/or high exogenous CHO availability [4, 5, 7]. The results of the present study provide novel 
insights into the mechanisms governing patterns of substrate oxidation in response to diet-exercise 
interactions. We report that compared to an isoenergetic high-protein diet, five days’ adaptation to 
a high-fat diet results in greater whole-body rates of fat oxidation during submaximal cycling and 
impairments in mitochondrial respiration. 
 
A series of independent studies over the past two decades [2, 4, 5, 7, 8] have compared 
high-fat versus high-CHO diets and shown that short-term (< 7 days) high-fat diets result in peak 
rates of whole-body fat oxidation of ~ 1 g·min-1 (~ 50 umol·kg·min-1), values that are typically 
two-fold greater than after isoenergetic high-CHO diets [2, 7]. The rates of fat oxidation in the 
present investigation (1.2 g·min-1) after an identical period of a fat-rich diet were similar to those 
reported previously. However, the first novel finding from the present study was that rates of fat 
oxidation were 33% greater than after five days of a low-CHO, HPRO diet (0.8 g·min-1). We report 
an increase in post-exercise plasma FFA concentration from pre-diet interventions in HFAT and 
HPRO, which likely contributed to the increased rates of fat oxidation after both conditions. 
However, the higher rates of fat oxidation in HFAT compared to HPRO are likely associated with 
altered rates of whole body lipolysis and subsequent storage of triglycerides [6, 16, 17]. Previous 
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work has shown higher rates of whole-body lipolysis, determined by elevated glycerol 
concentration, and this increase was associated with elevated intramuscular triglyceride (IMTG) 
concentration following fat-adaptation [6, 18]. Limited muscle biopsy sample did not permit 
IMTG measurements in the current study. It is also known that low-CHO availability reduces 
circulating insulin concentrations which could increase rates of whole-body fat oxidation. 
Although CHO intake was identical in both dietary conditions, it is likely that a proportion of 
protein in HPRO was converted to glucose via gluconeogenesis [19], which may explain slightly 
higher muscle glycogen concentrations post-diet in HPRO compared to HFAT. Higher availability 
of muscle glycogen likely contributes to lower rates of whole-body fat oxidation in HPRO 
compared to HFAT. Accordingly, the higher rates of fat oxidation measured after HFAT are likely 
driven by higher fat rather than higher CHO availability. 
 
Despite CHO intake being ‘clamped’ in both dietary conditions, rates of CHO oxidation 
were lower following five days HFAT compared to HPRO. Rates of CHO oxidation were reduced 
by 50% (3 g·min -1 to 1.5 g·min-1) following HFAT compared to a 25% decline (2.3 g·min-1) 
following HPRO. The greater oxidation of CHO-based fuels may be explained by the slightly 
higher muscle glycogen concentration post-diet in HPRO compared to HFAT, which has 
previously been shown to increase reliance on CHO-based fuels during subsequent exercise [20]. 
Without a protein tracer in the current study, we are unable to detect the proportion of protein that 
is being converted to glucose. Following a 6-day high-fat diet (63% EI from fat), Peters [21] 
observed a decrease in the active form of the rate limiting enzyme in CHO metabolism, pyruvate 
dehydrogenase (PDH), and consequently a reduction in rates of CHO oxidation during exercise, 
which was not observed following a moderate CHO diet (52% EI CHO). Therefore, a decrease in 
PDH activity may contribute towards the observed reduction in whole-body rates of CHO 
oxidation in the present study [5]; however, limitations in muscle biopsy sample did not permit 
assessment of PDH activity. 
 
To further determine potential mechanisms for reduced CHO oxidation, we assessed 
skeletal muscle mitochondrial respiration to measure dietary effects on substrate flux and 
utilization. We found that respiration supported by octanoylcarnitine and pyruvate (CI + ETFp) 
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was significantly reduced after five days of HFAT, but not HPRO, when CIII and/or CIV are 
operating at or near maximal activity. In our interpretations of mitochondrial respiration data 
obtained using the Oroboros O2k SUIT protocol, it is important to note that supra-physiological 
mitochondrial substrate concentrations and a sequential addition protocol are used. Therefore, 
interpretations of substrate-specific effects on respiration must be made with caution because this 
protocol does not allow us to pinpoint whether the addition of a particular substrate alone or any 
previously added substrate in the protocol are responsible for the effect. Nonetheless, it was 
surprising that FFA (i.e. octanoylcarnitine)-driven mitochondrial respiration (ETF leak) was not 
subsequently increased with HFAT. Decreased respiration observed following the addition of 
octanoylcarnitine and pyruvate is in line with previous studies reporting high-fat diets reduce the 
amount of PDH (in its active form [PDHa]) and PDHa activity at rest but not after a moderate 
CHO diet [21]. Alterations in PDH activity have further been identified as a mechanism underlying 
regulation of metabolic flexibility in isolated rodent skeletal muscle mitochondria in response to 
altered substrate availability induced by high-fat feeding [22]. In addition, the reduction in 
respiration after five days of HFAT persisted after uncoupling (ETS CI + CII + ETF and ETS CII), 
suggesting that the functional reductions in respiration occurred either at the level of CI/CII or 
downstream at CIII/CIV but not at CV (ATP-synthase). In line with the observed reductions in 
uncoupled respiration, Skovbro [23] observed that ETFp and uncoupled respiration were decreased 
following a longer high-fat feeding period (i.e. 16 days; 55-60% fat) compared to a moderate CHO 
diet (i.e. 55-60% CHO) [23]. The mitochondrial effects of HFAT in the present study may have 
been more pronounced following a longer dietary intervention period. Additionally, the type of the 
dietary fat intake has previously shown to affect mitochondrial function and morphology [24]. 
Lionetti [24] has shown that high saturated fat intake was associated with greater mitochondrial 
dysfunction compared to unsaturated fat in rodents. The current study provided a 65% fat diet, 
which was made up of 55% saturated fat, and whether the reductions in mitochondrial respiration 
would be observed with a different dietary fat composition requires further investigation. As no 
changes in mitochondrial respiration were observed following five days of HPRO, this suggests 
that the primary driver of these skeletal muscle adaptations is high dietary fat availability. Based 
on the evidence in the present study, the biochemical explanation of why HFAT results in increased 
whole body fat oxidation despite reduced skeletal muscle mitochondrial respiration is inconclusive 
and warrants future investigation of mitochondria in other tissues. Given that potential HFAT-
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induced changes in the delivery and transport of fatty acids across sarcolemma are removed in the 
ex vivo analysis of mitochondrial respiration, these additional variables may also contribute to the 
observed increases in fat oxidation at the whole body level.  
 
Although we observed changes in respiration following the addition of octanoylcarnitine 
and pyruvate and uncoupled respiration with HFAT, we detected no differences in skeletal muscle 
protein content of the five mitochondrial OXPHOS complexes after either dietary condition. 
Additionally, neither citrate synthase protein content nor maximal activity was changed. Given 
that changes in complex I and citrate synthase activity have strong associations with mitochondrial 
content (i.e. volume and/or density), this suggests that content is not affected by either short-term 
HFAT or HPRO availability [25]. Instead, we speculate that changes in enzyme activities 
regulating mitochondrial substrate flux likely contribute towards the reduced respiration observed 
after short-term adaptation to HFAT.  
 
To determine alternative enzymes and signaling pathways impacted by the HFAT and 
HPRO, we measured putative transporters with roles in skeletal muscle FA uptake, and two energy 
sensing metabolic signaling pathways, AMPK and mTOR. There was a 12% increase in 
FAT/CD36 protein observed following HFAT, suggesting potential increased capacity for 
sarcolemmal and/or mitochondrial membrane FA uptake, although this increase in FAT/CD36 did 
not reach statistical significance. No change in mitochondrial CPT1 was observed following five 
days of HFAT or HPRO. These findings are in agreement with previous work which reported that 
a high-fat diet together with an intensive training program resulted in significantly greater (i.e. 
17% increase) protein abundance of FAT/CD36 without change in gene expression of CPT1 [16]. 
Low CHO diets together with periods of endurance training have previously been shown to 
increase AMPK activation and signaling to its downstream substrate ACC [26]. However, no 
significant change was reported in AMPK Thr172 phosphorylation relative to total AMPK, or its 
substrate ACC Ser79 phosphorylation relative to total ACC following the dietary interventions. 
No differences post-diet were found in mTOR Ser2448 phosphorylation relative to total mTOR 
and phosphorylation of its substrate RPS6 Ser235/236 relative to total RPS6 in HFAT or HPRO. 
Together these findings suggest that FA transporter abundance and activation of these energy-
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sensing pathways were unaffected by the two diet interventions, perhaps as a result of the high 
training status of the cyclists and the ability to cope with the demand of the dietary overload. 
Further investigation is required to uncover alternative protein signaling pathways associated with 
changes in substrate metabolism that may underpin the dietary effects on skeletal muscle 
mitochondrial respiration.  
 
After CHO restoration strategies (e.g. 1 day of high-CHO diet, a pre-exercise CHO-rich 
breakfast and CHO intake during exercise) muscle glycogen increased in both HFAT and HPRO, 
but did not reach pre-intervention values in HFAT. This may be a result of the brief (24 h) CHO 
restoration period compared to five days of high CHO intake prior to baseline measures. Rates of 
fat oxidation and CHO oxidation returned towards baseline values during 100 min SS cycling in 
both HFAT and HPRO, and were similar to the results seen in the pre-diet protocol. However, the 
CHO restoration and exercise feeding protocols involved aggressive strategies to promote high 
CHO availability from both exogenous and endogenous sources, compared with overnight fasted 
and water fed conditions on the pre-diet protocol. Therefore, rates of fat oxidation were higher and 
CHO oxidation lower than expected during the 100 min steady state protocol on day 7, particularly 
with HFAT.  Indeed, although the present study did not include a direct comparison to a chronic 
high-CHO diet as in our prior investigations [2, 4, 7], our results are consistent with previous 
observations that muscle adaptation during chronic periods of a low-CHO diet, especially in the 
case of the HFAT, is sufficiently robust to persist despite the restoration of CHO [2, 4, 7].  For 
example, CHO oxidation rates following HFAT or HPRO and CHO restoration in the current 
study, were lower than those reported in previous studies following a controlled (chronic high-
CHO) diet (200-220 umol·kg·min-1 vs. 250-300 umol·kg·min-1) [7]. Muscle glycogen utilization 
in the current study was ~100 mmol·kg DM lower than those previously reported with HFAT 
intervention [2] and was slightly higher in HPRO compared to HFAT. This difference may be 
related to higher pre-exercise muscle glycogen in HPRO. Overall, this reduced capacity for CHO 
oxidation in HFAT, despite the availability of exogenous and endogenous stores was previously 
associated with persistent downregulation of PDH activity [5].  
Whole body rates of fat oxidation after CHO restoration remained slightly higher after 
HFAT compared to HPRO, but this resulted in only a small difference in the total fat oxidized 
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during 100 min SS cycling (~ 15 g over 100 min).  No difference was measured for FFA 
concentrations between the two dietary conditions, although plasma glycerol concentrations were 
greater during exercise following HFAT compared to HPRO. The elevated glycerol concentration 
following HFAT indicates a greater rate of whole-body lipolysis which could be associated with 
greater IMTG utilization and/or liberation of FFA into the blood, contributing to the minor 
variation in rates of whole-body fat oxidation between HFAT and HPRO.  Corresponding to total 
fat utilization, there were only minor differences in total CHO oxidized between HFAT and HPRO 
(~ 30 g) during 100 min of exercise.  
 
Although one day of high CHO availability in the current study failed to fully reverse the 
differences in whole-body rates of substrate oxidation, it was sufficient to restore the decreased 
mitochondrial respiration (CI + ETFp) from HFAT, back to pre-diet values. This indicates that 
there may be an additional underlying mechanism regulating changes in substrate oxidation (i.e. 
downregulating CHO oxidation) and mitochondrial respiration. As the current study precluded 
investigation of a high-CHO trial due to the high number of biopsies that would have been 
required, we are unable to speculate whether differences in mitochondrial respiration would have 
been observed between the three dietary conditions. We also reported greater post-exercise 
reductions in CI + ETFp and CI + CII + ETFp respiration in HFAT than HPRO and this was not 
attributable to reductions to citrate synthase protein or activity. These effects of exercise following 
the HFAT may be attributable to mitochondrial adaptations at the cessation of exercise that impact 
ETC, including changes in signaling, mitochondrial membrane dynamics and/or buffering of 
reactive oxygen species. It should also be noted that there could have been damage to myofibers 
during separation and permeabilization. This could limit the interpretation of the respiratory values 
prior to the addition of cytochrome C in the SUIT protocol since it occasionally increased O2 flux 
more than 10% above CI+CII+ETFp (Table 2). Despite this, we are confident that the data prior 
to the addition of cytochrome C is still meaningful since the effect was consistent across all trials. 
To determine the effect of potential shifts in substrate utilization on exercise performance, previous 
studies have included a cycling TT after a bout of steady state exercise, following the high-CHO 
intake.  Burke [2] reported similar TT performance between high-fat and high-CHO trials and in 
the present study we did not detect any difference in TT performance between HFAT and HPRO 
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after one day of CHO restoration; however, we cannot compare this performance to a high-CHO 
condition and therefore the shifts in substrate utilization require further investigation. 
 
In conclusion, the results of the present investigation demonstrate that whole-body rates of 
fat oxidation increase to a greater extent in trained humans following high dietary fat intake 
compared to a high-protein diet, with CHO ‘clamped’ at 20% of energy intake. High dietary fat 
also reduced mitochondrial respiration supported by octanoylcarnitine and pyruvate as well as 
uncoupled respiration. These reductions in mitochondrial 'function' may be compensatory, and not 
solely 'driving' fuel regulation under the conditions of our investigation. Further mechanistic 
investigation into potential underlying diet-induced differences in mitochondrial membrane 
dynamics, mitochondrial complex subunits and additional enzymes regulating mitochondrial 
substrate flux is warranted.  The acute but aggressive restoration of endogenous and exogenous 
CHO availability was unable to completely restore normal rates of substrate oxidation but was able 
to reverse the fat-induced disruption of mitochondrial respiration. Together these findings 
demonstrate the impact a high-fat diet has on metabolic flexibility and skeletal muscle 
mitochondrial respiration in trained cyclists.   
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Figure Legends 
Figure 1: An overview of the study design showing the five days high-CHO diet followed by five 
days high-fat or high-protein diet (D1 to D7) with one day of a high-CHO diet. CHO, carbohydrate; 
HIIT, high-intensity interval training; TT, time-trial.  
Figure 2: Resting muscle glycogen levels following five days high-CHO (Pre-diet D1), five days 
high-fat or high-protein (Post-diet D6), one day of a high-CHO diet (D7 Pre Ex) and following 
100 min SS cycling at 63% PPO (D7 Post Ex) (A) and muscle glycogen percent change from Pre-
diet (D1) to Post-diet (D6), from Post-diet (D6) to D7 Pre Ex and from D7 Pre Ex to D7 Post Ex 
(B) . Values are mean ± SD for n=6. a HFAT different to Pre-diet (D1) within condition; b HPRO 
different to Pre-diet (D1) within condition; c HFAT different to D7 Pre Ex and D7 Post Ex within 
condition; d HPRO different to D7 Pre Ex and D7 Post Ex within condition.  
Figure 3: RER (A) and rates of CHO (B) and fat oxidation (C) following five days high CHO 
(Baseline and Pre-diet D1), five days high-fat or high-protein (Post-diet D6) during 20 min cycling 
and following one day of a high-CHO diet (D720-100) during 100 min SS cycling at 63% PPO. 
Values are mean ± SD. # HFAT different to HPRO at time point; e HFAT different to Baseline 
within condition; f HPRO different to Baseline within condition; a HFAT different to Pre-diet 
(D1); b HPRO different to Pre-diet (D1) within condition.   
Figure 4: Effect of five days high-fat diet or high-protein and one day of a high-CHO diet on 
plasma glycerol (A), FFA (B), βHB (C), blood glucose (D), plasma insulin (E) and blood lactate 
concentration (F) before and during 100 min cycling at 63% PPO. Values are mean ± SD. # HFAT 
different to HPRO at time point; g HFAT different to T=0 within condition; h HPRO different to 
T=0 within condition; $ different to all time points within each condition. 
Figure 5: Effect of five days high-fat or high-protein diet (A), one day of a high-CHO diet (B), 
100 min SS cycling at 63% PPO (C) on mitochondrial respiration using a sequential addition 
protocol. Respiratory states are supported by single or convergent electron input via complex I 
(CI), complex II (CII) and/or electron transfer flavoprotein (ETF) under non-phosphorylating 
(Leak) conditions, state-3 oxidative phosphorylation in the presence of ADP (indicated by “p”), or 
with an uncoupler (FCCP) to assess maximal electron transport system (ETS) activity. Values are 
mean ± SD as a fold change from respective day indicated in each figure panel. Differences in 
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respiratory fluxes were not due to altered overall mitochondrial content as indicated by citrate 
synthase activity (D) or protein content (E). * O2 flux per mass different from Pre-Diet D1 (A); 
Post-Diet D6 (B); Pre-Ex D7 (C) of the respective high-fat or high-protein diet. # HFAT different 
to HPRO condition at time point. 
Figure 6: Skeletal muscle protein content (A-E) and representative images (F) of five OXPHOS 
complexes following five days high-CHO diet, five days high-fat or high-protein diet, one day of 
a high-CHO diet and following 100 min SS cycling at 63% PPO . Values are mean ±SD as a fold 
change relative to resting pre-diet D1 values.  
Figure 7: Skeletal muscle protein content and representative blots of fat (CD36, CPT1a) (A & B), 
fat/CHO (p- Thr172 AMPK/Total, p-Ser79 ACC/Total) (C & D) and protein regulatory signaling 
pathways (p-Ser2448 mTOR/Total, p-Ser235/236 RPS6/Total) (E & F) following five days high-
CHO, five days high-fat or high-protein diet, one day of a high-CHO diet and following 100 min 
SS cycling. Values are mean ± SD as a fold change relative to resting pre-diet D1 values. # HFAT 
different to HPRO at time point; i HFAT different to D7 Post Ex within condition, j HPRO 
different to D7 Post Ex within condition. 
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Tables 
Table 1: Macronutrient content of the high-carbohydrate (HCHO), high-fat (HFAT) and high-protein (HPRO) diets consumed. Total 
Energy Intake (TEI). 
 
  
  Energy  Carbohydrate Protein Fat 
  MJ MJ/kg Total (g) g/kg % TEI Total (g) g/kg %TEI Total (g) g/kg % TEI 
HCHO 17.0 ± 1.4 0.22 ± 0.0 769.4 ± 63.4 10.0 ± 0.1 73.0 ± 0.5 140.5 ± 11.8 1.8 ± 0.0 14.2 ± 0.4 58.2 ± 6.3 0.8 ± 0.0 12.8 ± 0.8 
HFAT 17.0 ± 1.5 0.22 ± 0.0 196.1 ± 19.7 2.5 ± 0.1 18.3 ± 0.7 138.7 ± 10.7 1.8 ± 0.1 13.7 ± 0.4 315.5 ± 26.8 4.1 ± 0.1 68.0 ± 0.6 
HPRO 17.0 ± 1.5 0.22 ± 0.0 200.3 ± 19.5 2.6 ± 0.1 18.5 ± 1.0 679.8 ± 66.7 8.8 ± 0.5 66.7 ± 0.9 69.3 ± 7.4 0.9 ±  0.1 14.8 ± 0.7 
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Table 2: Effects of five days high-fat or high-protein diet, one day of a high-CHO diet and 100 min SS cycling at 63% PPO on 
mitochondrial respiration. Respiratory states are supported by single or convergent electron input via complex I (CI), complex II (CII) 
and/or electron transfer flavoprotein (ETF) under non-phosphorylating (Leak) conditions, state-3 oxidative phosphorylation in the 
presence of ADP (indicated by “p”), or with an uncoupler (FCCP) to assess maximal electron transport system (ETS) activity. Values 
are mean ± SD. a HFAT different to D7 Post Ex; b HPRO different to D7 Post Ex within condition;  c HFAT different to D6. 
  
O2k respiration measure; O2 flux per mass (pmol/s/mg)); mean ± SD) 
 ETF Leak ETFp CI + ETFp 
CI + CII + 
ETFp 
cyt-c test 
ETS CI + CII + 
ETF 
ETS CII 
Substrate/Uncoupler/ 
Inhibitor  
 
malate, 
octanoylcarnitine 
ADP pyruvate succinate cytochrome c FCCP Rotenone 
HFAT Pre-Diet (D1) 20.2 ± 5.9 43.8 ± 5.8 62.5 ± 11.2 
a
 116.8 ± 22.6
 a c
 136.6 ± 29.5 
a
 
c
 144.4 ± 32.2 
a
 
c
 92.5 ± 19.0
 a
 
c
 
HPRO Pre-Diet (D1) 17.5 ± 4.1 47.7 ± 5.6 66.1 ± 15.2 125.0 ± 31.2
 b
 147.1 ± 37.0
 b
 154.9 ± 37.3 
b
 100.6 ± 30.3
 b
 
HFAT Post-Diet (D6) 21.0 ± 4.9 42.8 ± 7.0 55.7 ± 13.5 103.5 ± 27.2
 a
 119.1 ± 39.2
 a
 124.0 ± 38.4 77.2 ± 30.5
 a
 
HPRO Post-Diet (D6) 19.1 ± 3.8 50.7 ± 4.5 68.4 ± 15.4 
b
 122.0 ± 26.9
 b
 140.3 ± 34.4
 b
 148.2 ± 37.2
 b
 91.3 ± 21.5
 b
 
HFAT D7 Pre Ex 24.6 ± 5.7 52.4 ± 7.2 64.3 ± 13.9
 a
 120.1 ± 29.0
 a
 141.1 ± 39.7 
a
 145.9 ± 38.8
 a
 92.9 ± 27.3
 a
 
HPRO D7 Pre Ex 18.7 ± 5.9 49.8 ± 12.8 64.8 ± 20.3 120.0 ± 36.9
 b
 142.9 ± 47.3
 b
 151.9 ± 51.0 
b
 97.3 ± 33.6
 b
 
HFAT D7 Post Ex 24.6 ± 4.9 44.7 ± 9.8 47.6 ± 13.8 84.0 ± 23.8 99.0 ± 26.7 108.1 ± 31.0 60.8 ± 20.5 
HPRO D7 Post Ex 21.7 ± 5.9 47.9 ± 11.3 56.8 ± 18.3 101.1 ± 30.2 105.4 ± 35.4 115.0 ± 37.4 65.4 ± 27.0 
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